0 XP   0   0   0

Akzo Nobel NV ADR
Buy, Hold or Sell?

I guess you are interested in Akzo Nobel NV ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Akzo Nobel NV ADR

Let's start. I'm going to help you getting a better view of Akzo Nobel NV ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Akzo Nobel NV ADR even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Akzo Nobel NV ADR is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Akzo Nobel NV ADR. The closing price on 2022-10-03 was $19.80 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Akzo Nobel NV ADR Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

1.1. Profitability of Akzo Nobel NV ADR.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Akzo Nobel NV ADR earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Akzo Nobel NV ADR to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 3.7% means that $[indicator name=netProfitMargin&period=MRQ&percentage=1 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Akzo Nobel NV ADR:

  • The MRQ is 3.7%. The company is making a profit. +1
  • The TTM is 6.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ3.7%TTM6.1%-2.4%
TTM6.1%YOY9.3%-3.2%
TTM6.1%5Y19.7%-13.6%
5Y19.7%10Y17.3%+2.5%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%7.1%-3.4%
TTM6.1%6.1%+0.0%
YOY9.3%6.5%+2.8%
5Y19.7%6.0%+13.7%
10Y17.3%6.1%+11.2%
1.1.2. Return on Assets

Shows how efficient Akzo Nobel NV ADR is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Akzo Nobel NV ADR to the Specialty Chemicals industry mean.
  • 0.7% Return on Assets means that Akzo Nobel NV ADR generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Akzo Nobel NV ADR:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.7%TTM1.1%-0.4%
TTM1.1%YOY1.6%-0.6%
TTM1.1%5Y2.7%-1.7%
5Y2.7%10Y2.5%+0.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7%1.6%-0.9%
TTM1.1%1.4%-0.3%
YOY1.6%1.5%+0.1%
5Y2.7%1.4%+1.3%
10Y2.5%1.4%+1.1%
1.1.3. Return on Equity

Shows how efficient Akzo Nobel NV ADR is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Akzo Nobel NV ADR to the Specialty Chemicals industry mean.
  • 2.0% Return on Equity means Akzo Nobel NV ADR generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Akzo Nobel NV ADR:

  • The MRQ is 2.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.0%TTM2.8%-0.8%
TTM2.8%YOY3.7%-0.9%
TTM2.8%5Y5.3%-2.4%
5Y5.3%10Y5.0%+0.3%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0%2.9%-0.9%
TTM2.8%2.8%+0.0%
YOY3.7%2.8%+0.9%
5Y5.3%2.5%+2.8%
10Y5.0%2.6%+2.4%

1.2. Operating Efficiency of Akzo Nobel NV ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Akzo Nobel NV ADR is operating .

  • Measures how much profit Akzo Nobel NV ADR makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Akzo Nobel NV ADR to the Specialty Chemicals industry mean.
  • An Operating Margin of 7.0% means the company generated $0.07  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Akzo Nobel NV ADR:

  • The MRQ is 7.0%. The company is operating less efficient.
  • The TTM is 8.6%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.0%TTM8.6%-1.6%
TTM8.6%YOY13.1%-4.4%
TTM8.6%5Y10.5%-1.9%
5Y10.5%10Y9.2%+1.3%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ7.0%8.9%-1.9%
TTM8.6%7.6%+1.0%
YOY13.1%9.0%+4.1%
5Y10.5%7.6%+2.9%
10Y9.2%6.3%+2.9%
1.2.2. Operating Ratio

Measures how efficient Akzo Nobel NV ADR is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 1.57 means that the operating costs are $1.57 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Akzo Nobel NV ADR:

  • The MRQ is 1.566. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.536. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.566TTM1.536+0.030
TTM1.536YOY1.431+0.105
TTM1.5365Y1.489+0.047
5Y1.48910Y1.326+0.163
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5661.617-0.051
TTM1.5361.5360.000
YOY1.4311.426+0.005
5Y1.4891.365+0.124
10Y1.3261.133+0.193

1.3. Liquidity of Akzo Nobel NV ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Akzo Nobel NV ADR is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 1.17 means the company has $1.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Akzo Nobel NV ADR:

  • The MRQ is 1.169. The company is just able to pay all its short-term debts.
  • The TTM is 1.183. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.169TTM1.183-0.014
TTM1.183YOY1.586-0.403
TTM1.1835Y1.573-0.390
5Y1.57310Y1.535+0.038
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1691.791-0.622
TTM1.1831.737-0.554
YOY1.5861.751-0.165
5Y1.5731.697-0.124
10Y1.5351.501+0.034
1.3.2. Quick Ratio

Measures if Akzo Nobel NV ADR is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Akzo Nobel NV ADR to the Specialty Chemicals industry mean.
  • A Quick Ratio of 0.64 means the company can pay off $0.64 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Akzo Nobel NV ADR:

  • The MRQ is 0.638. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.598. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.638TTM0.598+0.040
TTM0.598YOY0.761-0.163
TTM0.5985Y0.772-0.174
5Y0.77210Y0.757+0.015
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6380.812-0.174
TTM0.5980.833-0.235
YOY0.7610.869-0.108
5Y0.7720.818-0.046
10Y0.7570.808-0.051

1.4. Solvency of Akzo Nobel NV ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Akzo Nobel NV ADR assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Debt to Asset Ratio of 0.66 means that Akzo Nobel NV ADR assets are financed with 66.4% credit (debt) and the remaining percentage (100% - 66.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Akzo Nobel NV ADR:

  • The MRQ is 0.664. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.618. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.664TTM0.618+0.047
TTM0.618YOY0.552+0.065
TTM0.6185Y0.550+0.068
5Y0.55010Y0.554-0.004
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6640.442+0.222
TTM0.6180.430+0.188
YOY0.5520.435+0.117
5Y0.5500.429+0.121
10Y0.5540.429+0.125
1.4.2. Debt to Equity Ratio

Measures if Akzo Nobel NV ADR is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Debt to Equity ratio of 206.6% means that company has $2.07 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Akzo Nobel NV ADR:

  • The MRQ is 2.066. The company is just not able to pay all its debts with equity.
  • The TTM is 1.706. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.066TTM1.706+0.360
TTM1.706YOY1.281+0.425
TTM1.7065Y1.334+0.372
5Y1.33410Y1.343-0.009
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0660.800+1.266
TTM1.7060.765+0.941
YOY1.2810.777+0.504
5Y1.3340.792+0.542
10Y1.3430.812+0.531

2. Market Valuation of Akzo Nobel NV ADR

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Akzo Nobel NV ADR.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 6.49 means the investor is paying $6.49 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Akzo Nobel NV ADR:

  • The EOD is 5.873. Very good. +2
  • The MRQ is 6.493. Very good. +2
  • The TTM is 7.496. Very good. +2
Trends
Current periodCompared to+/- 
EOD5.873MRQ6.493-0.620
MRQ6.493TTM7.496-1.003
TTM7.496YOY10.386-2.890
TTM7.4965Y11.517-4.021
5Y11.51710Y11.784-0.266
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD5.87313.400-7.527
MRQ6.49314.168-7.675
TTM7.49617.196-9.700
YOY10.38615.411-5.025
5Y11.51716.788-5.271
10Y11.78418.084-6.300
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Akzo Nobel NV ADR.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Akzo Nobel NV ADR:

  • The MRQ is -0.244. Very Bad. -2
  • The TTM is 0.246. Very good. +2
Trends
Current periodCompared to+/- 
MRQ-0.244TTM0.246-0.490
TTM0.246YOY0.999-0.753
TTM0.2465Y0.026+0.219
5Y0.02610Y0.0260.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2440.026-0.270
TTM0.2460.043+0.203
YOY0.9990.036+0.963
5Y0.0260.003+0.023
10Y0.0260.015+0.011

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Akzo Nobel NV ADR is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 0.72 means the investor is paying $0.72 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Akzo Nobel NV ADR:

  • The EOD is 0.647. Very good. +2
  • The MRQ is 0.716. Very good. +2
  • The TTM is 0.996. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.647MRQ0.716-0.068
MRQ0.716TTM0.996-0.280
TTM0.996YOY1.166-0.171
TTM0.9965Y0.562+0.433
5Y0.56210Y0.450+0.112
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD0.6471.944-1.297
MRQ0.7162.150-1.434
TTM0.9962.421-1.425
YOY1.1662.151-0.985
5Y0.5622.072-1.510
10Y0.4501.652-1.202

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Akzo Nobel NV ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--30.58031.038-1%31.853-4%17.560+74%14.048+118%
Book Value Per Share Growth---1.427-0.336-76%0.039-3774%2.780-151%2.780-151%
Current Ratio--1.1691.183-1%1.586-26%1.573-26%1.535-24%
Debt To Asset Ratio--0.6640.618+8%0.552+20%0.550+21%0.554+20%
Debt To Equity Ratio--2.0661.706+21%1.281+61%1.334+55%1.343+54%
Dividend Per Share--1.5360.907+69%0.888+73%0.966+59%0.966+59%
Eps--0.5970.843-29%1.148-48%0.730-18%0.667-11%
Eps Growth---26.59517.286-254%52.069-151%34.359-177%34.359-177%
Gains Per Share--0.1090.571-81%0.927-88%3.746-97%3.746-97%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.0370.061-39%0.093-60%0.197-81%0.173-78%
Operating Margin--0.0700.086-19%0.131-46%0.105-33%0.092-24%
Operating Ratio--1.5661.536+2%1.431+9%1.489+5%1.326+18%
Pb Ratio0.647-11%0.7160.996-28%1.166-39%0.562+27%0.450+59%
Pe Ratio5.873-11%6.4937.496-13%10.386-37%11.517-44%11.784-45%
Peg Ratio---0.2440.246-199%0.999-124%0.026-1026%0.026-1026%
Price Per Share19.800-11%21.89030.893-29%37.160-41%31.303-30%29.878-27%
Quick Ratio--0.6380.598+7%0.761-16%0.772-17%0.757-16%
Return On Assets--0.0070.011-38%0.016-59%0.027-76%0.025-74%
Return On Equity--0.0200.028-28%0.037-45%0.053-61%0.050-59%
 EOD+3 -0MRQTTM+6 -13YOY+5 -145Y+5 -1410Y+5 -14

3.2. Fundamental Score

Let's check the fundamental score of Akzo Nobel NV ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-155.873
Price to Book Ratio (EOD)Between0-10.647
Net Profit Margin (MRQ)Greater than00.037
Operating Margin (MRQ)Greater than00.070
Quick Ratio (MRQ)Greater than10.638
Current Ratio (MRQ)Greater than11.169
Debt to Asset Ratio (MRQ)Less than10.664
Debt to Equity Ratio (MRQ)Less than12.066
Return on Equity (MRQ)Greater than0.150.020
Return on Assets (MRQ)Greater than0.050.007
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Akzo Nobel NV ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.240
Ma 20Greater thanMa 5019.836
Ma 50Greater thanMa 10021.392
Ma 100Greater thanMa 20023.221
OpenGreater thanClose19.420
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets16,185,000
Total Liabilities10,751,000
Total Stockholder Equity5,204,000
 As reported
Total Liabilities 10,751,000
Total Stockholder Equity+ 5,204,000
Total Assets = 16,185,000

Assets

Total Assets16,185,000
Total Current Assets7,031,000
Long-term Assets7,031,000
Total Current Assets
Cash And Cash Equivalents 1,076,000
Short-term Investments 782,000
Net Receivables 3,055,000
Inventory 2,118,000
Total Current Assets  (as reported)7,031,000
Total Current Assets  (calculated)7,031,000
+/-0
Long-term Assets
Property Plant Equipment 2,256,000
Long-term Assets Other 2,601,000
Long-term Assets  (as reported)9,154,000
Long-term Assets  (calculated)4,857,000
+/- 4,297,000

Liabilities & Shareholders' Equity

Total Current Liabilities6,017,000
Long-term Liabilities4,734,000
Total Stockholder Equity5,204,000
Total Current Liabilities
Accounts payable 2,657,000
Other Current Liabilities 1,041,000
Total Current Liabilities  (as reported)6,017,000
Total Current Liabilities  (calculated)3,698,000
+/- 2,319,000
Long-term Liabilities
Other Liabilities 1,330,000
Long-term Liabilities  (as reported)4,734,000
Long-term Liabilities  (calculated)1,330,000
+/- 3,404,000
Total Stockholder Equity
Common Stock89,000
Retained Earnings 5,491,000
Other Stockholders Equity -376,000
Total Stockholder Equity (as reported)5,204,000
Total Stockholder Equity (calculated)5,204,000
+/-0
Other
Capital Stock89,000
Common Stock Shares Outstanding 177,700
Net Invested Capital 5,204,000
Net Tangible Assets 907,000
Net Working Capital 1,014,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-30
> Total Assets 
18,468,000
18,032,000
17,083,000
16,672,000
15,946,000
18,508,741
19,428,366
20,399,803
19,557,728
19,289,187
21,546,226
15,961,000
14,433,000
14,045,000
12,984,000
13,171,000
13,208,000
13,248,000
13,177,000
13,394,000
13,898,000
13,457,000
13,878,000
15,651,000
16,185,000
16,185,00015,651,00013,878,00013,457,00013,898,00013,394,00013,177,00013,248,00013,208,00013,171,00012,984,00014,045,00014,433,00015,961,00021,546,22619,289,18719,557,72820,399,80319,428,36618,508,74115,946,00016,672,00017,083,00018,032,00018,468,000
   > Total Current Assets 
6,760,000
7,024,000
6,178,000
6,139,000
5,912,000
6,891,939
10,859,853
11,520,482
11,078,911
11,043,066
13,320,716
7,748,000
6,480,000
5,899,000
4,744,000
4,359,000
4,719,000
5,041,000
5,064,000
5,169,000
5,487,000
5,143,000
5,348,000
7,091,000
7,031,000
7,031,0007,091,0005,348,0005,143,0005,487,0005,169,0005,064,0005,041,0004,719,0004,359,0004,744,0005,899,0006,480,0007,748,00013,320,71611,043,06611,078,91111,520,48210,859,8536,891,9395,912,0006,139,0006,178,0007,024,0006,760,000
       Cash And Cash Equivalents 
1,479,000
1,890,000
1,560,000
1,268,000
1,042,000
1,274,199
1,587,607
1,409,767
1,114,991
1,203,982
3,210,599
1,334,000
1,158,000
625,000
1,263,000
832,000
1,230,000
1,502,000
1,606,000
1,197,000
1,216,000
1,087,000
1,152,000
1,418,000
1,076,000
1,076,0001,418,0001,152,0001,087,0001,216,0001,197,0001,606,0001,502,0001,230,000832,0001,263,000625,0001,158,0001,334,0003,210,5991,203,9821,114,9911,409,7671,587,6071,274,1991,042,0001,268,0001,560,0001,890,0001,479,000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
6,262,904
2,701,000
1,526,000
1,576,000
138,000
2,000
50,000
110,000
250,000
301,000
295,000
13,000
58,000
1,081,000
782,000
782,0001,081,00058,00013,000295,000301,000250,000110,00050,0002,000138,0001,576,0001,526,0002,701,0006,262,9040000000000
       Net Receivables 
3,454,000
3,311,000
3,002,000
3,166,000
3,186,000
3,629,004
2,385,013
2,740,805
2,821,229
2,633,712
2,476,485
2,406,000
2,491,000
2,404,000
2,154,000
2,250,000
2,191,000
2,228,000
2,009,000
2,304,000
2,506,000
2,380,000
2,436,000
2,740,000
3,055,000
3,055,0002,740,0002,436,0002,380,0002,506,0002,304,0002,009,0002,228,0002,191,0002,250,0002,154,0002,404,0002,491,0002,406,0002,476,4852,633,7122,821,2292,740,8052,385,0133,629,0043,186,0003,166,0003,002,0003,311,0003,454,000
       Inventory 
1,761,000
1,762,000
1,616,000
1,639,000
1,629,000
1,910,126
1,313,798
1,433,141
1,364,060
1,331,327
1,306,492
1,226,000
1,225,000
1,221,000
1,139,000
1,210,000
1,178,000
1,134,000
1,159,000
1,303,000
1,400,000
1,564,000
1,650,000
1,852,000
2,118,000
2,118,0001,852,0001,650,0001,564,0001,400,0001,303,0001,159,0001,134,0001,178,0001,210,0001,139,0001,221,0001,225,0001,226,0001,306,4921,331,3271,364,0601,433,1411,313,7981,910,1261,629,0001,639,0001,616,0001,762,0001,761,000
       Other Current Assets 
67,000
61,000
62,000
66,000
55,000
78,611
5,538,609
5,936,770
5,778,631
5,874,045
6,882
81,000
80,000
73,000
9,000
65,000
70,000
67,000
10,000
64,000
70,000
99,000
15,000
0
0
0015,00099,00070,00064,00010,00067,00070,00065,0009,00073,00080,00081,0006,8825,874,0455,778,6315,936,7705,538,60978,61155,00066,00062,00061,00067,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
8,213,000
7,953,000
8,146,000
8,240,000
8,812,000
8,489,000
8,207,000
8,113,000
8,225,000
8,411,000
8,314,000
8,530,000
8,560,000
9,154,000
9,154,0008,560,0008,530,0008,314,0008,411,0008,225,0008,113,0008,207,0008,489,0008,812,0008,240,0008,146,0007,953,0008,213,00000000000000
       Property Plant Equipment 
4,480,000
4,484,000
4,419,000
4,198,000
4,063,000
4,731,902
2,200,072
2,133,104
2,001,862
1,965,733
2,005,047
2,699,586
2,051,000
2,039,000
2,074,000
2,000,000
1,979,000
1,914,000
1,945,000
2,024,000
2,018,000
2,023,000
2,104,000
2,098,000
2,256,000
2,256,0002,098,0002,104,0002,023,0002,018,0002,024,0001,945,0001,914,0001,979,0002,000,0002,074,0002,039,0002,051,0002,699,5862,005,0471,965,7332,001,8622,133,1042,200,0724,731,9024,063,0004,198,0004,419,0004,484,0004,480,000
       Goodwill 
0
0
1,553,000
0
0
0
1,134,862
0
0
0
1,135,582
0
0
0
1,093,000
0
0
0
1,096,000
0
0
0
1,155,000
0
0
001,155,0000001,096,0000001,093,0000001,135,5820001,134,8620001,553,00000
       Long Term Investments 
0
0
170,000
1,495,000
1,448,000
1,642,614
141,708
1,289,211
1,250,000
1,215,559
157,146
4,080,998
4,239,313
2,988,248
908,117
0
0
0
0
0
0
0
0
0
0
0000000000908,1172,988,2484,239,3134,080,998157,1461,215,5591,250,0001,289,211141,7081,642,6141,448,0001,495,000170,00000
       Intangible Assets 
4,515,000
4,460,000
4,655,000
4,384,000
4,231,000
4,918,456
2,959,049
4,157,953
3,943,203
3,882,843
2,830,925
12,147,842
12,846,518
8,773,950
2,532,000
0
0
0
2,458,000
0
0
0
2,535,000
0
0
002,535,0000002,458,0000002,532,0008,773,95012,846,51812,147,8422,830,9253,882,8433,943,2034,157,9532,959,0494,918,4564,231,0004,384,0004,655,0004,460,0004,515,000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
8,213,000
7,953,000
8,146,000
8,240,000
3,248,000
2,937,000
2,770,000
0
2,573,000
2,765,000
2,646,000
0
2,745,000
2,601,000
2,601,0002,745,00002,646,0002,765,0002,573,00002,770,0002,937,0003,248,0008,240,0008,146,0007,953,0008,213,00000000000000
> Total Liabilities 
10,343,000
10,345,000
9,664,000
9,522,000
9,175,000
10,461,105
11,854,209
12,513,224
11,951,816
11,583,700
7,738,013
7,136,000
7,056,000
7,026,000
6,416,000
6,480,000
7,153,000
7,197,000
7,227,000
7,290,000
7,973,000
7,732,000
8,242,000
9,989,000
10,751,000
10,751,0009,989,0008,242,0007,732,0007,973,0007,290,0007,227,0007,197,0007,153,0006,480,0006,416,0007,026,0007,056,0007,136,0007,738,01311,583,70011,951,81612,513,22411,854,20910,461,1059,175,0009,522,0009,664,00010,345,00010,343,000
   > Total Current Liabilities 
4,824,000
4,766,000
4,444,000
4,646,000
4,414,000
4,924,322
7,592,170
8,174,437
7,898,045
7,586,247
4,221,152
3,735,000
3,692,000
3,594,000
3,002,000
3,010,000
2,894,000
2,998,000
3,093,000
3,231,000
3,850,000
4,407,000
4,869,000
5,470,000
6,017,000
6,017,0005,470,0004,869,0004,407,0003,850,0003,231,0003,093,0002,998,0002,894,0003,010,0003,002,0003,594,0003,692,0003,735,0004,221,1527,586,2477,898,0458,174,4377,592,1704,924,3224,414,0004,646,0004,444,0004,766,0004,824,000
       Short-term Debt 
283,000
183,000
92,000
3,069,000
2,952,000
3,258,242
960,730
4,603,272
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000004,603,272960,7303,258,2422,952,0003,069,00092,000183,000283,000
       Short Long Term Debt 
283,000
183,000
92,000
3,069,000
2,952,000
3,258,242
960,730
4,603,272
2,254,498,803
137,943,371,524,690
586,144
710,000
709,000
700,000
79,000
0
0
0
33,000
0
0
0
1,469,000
0
0
001,469,00000033,00000079,000700,000709,000710,000586,144137,943,371,524,6902,254,498,8034,603,272960,7303,258,2422,952,0003,069,00092,000183,000283,000
       Accounts payable 
3,708,000
3,793,000
3,907,000
3,591,000
2,477,000
2,861,668
1,950,282
2,258,580
2,216,015
2,102,339
1,805,460
2,595,000
2,550,000
2,454,000
1,883,000
1,789,000
1,711,000
1,863,000
2,032,000
2,119,000
2,277,000
2,360,000
2,376,000
2,473,000
2,657,000
2,657,0002,473,0002,376,0002,360,0002,277,0002,119,0002,032,0001,863,0001,711,0001,789,0001,883,0002,454,0002,550,0002,595,0001,805,4602,102,3392,216,0152,258,5801,950,2822,861,6682,477,0003,591,0003,907,0003,793,0003,708,000
       Other Current Liabilities 
832,000
790,000
445,000
633,000
1,630,000
1,904,259
3,839,318
4,139,501
3,881,518
3,813,383
1,202,111
430,000
433,000
440,000
493,000
926,000
999,000
968,000
376,000
971,000
966,000
964,000
397,000
989,000
1,041,000
1,041,000989,000397,000964,000966,000971,000376,000968,000999,000926,000493,000440,000433,000430,0001,202,1113,813,3833,881,5184,139,5013,839,3181,904,2591,630,000633,000445,000790,000832,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
3,401,000
3,364,000
3,432,000
3,414,000
3,470,000
4,259,000
4,199,000
4,134,000
4,059,000
4,123,000
3,325,000
3,373,000
4,519,000
4,734,000
4,734,0004,519,0003,373,0003,325,0004,123,0004,059,0004,134,0004,199,0004,259,0003,470,0003,414,0003,432,0003,364,0003,401,00000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
352,000
0
0
0
324,000
0
0
0
299,000
0
0
00299,000000324,000000352,00000000000000000
       Other Liabilities 
0
0
2,045,000
2,229,000
2,116,000
2,436,935
1,499,940
1,511,871
1,378,026
1,338,273
1,453,315
1,679,854
1,326,000
1,394,000
1,372,000
1,434,000
1,480,000
1,438,000
1,363,000
1,294,000
1,362,000
1,325,000
1,379,000
1,341,000
1,330,000
1,330,0001,341,0001,379,0001,325,0001,362,0001,294,0001,363,0001,438,0001,480,0001,434,0001,372,0001,394,0001,326,0001,679,8541,453,3151,338,2731,378,0261,511,8711,499,9402,436,9352,116,0002,229,0002,045,00000
> Total Stockholder Equity
8,125,000
7,687,000
6,912,000
6,656,000
6,291,000
7,509,093
7,043,353
7,333,005
7,074,022
7,212,318
13,574,214
8,611,000
7,159,000
6,791,000
6,350,000
6,477,000
5,847,000
5,847,000
5,746,000
5,889,000
5,708,000
5,509,000
5,425,000
5,448,000
5,204,000
5,204,0005,448,0005,425,0005,509,0005,708,0005,889,0005,746,0005,847,0005,847,0006,477,0006,350,0006,791,0007,159,0008,611,00013,574,2147,212,3187,074,0227,333,0057,043,3537,509,0936,291,0006,656,0006,912,0007,687,0008,125,000
   Common Stock
0
0
504,000
505,000
505,000
591,341
606,461
622,463
595,903
592,730
587,291
143,341
114,000
105,000
100,000
100,000
97,000
95,000
95,000
95,000
95,000
94,000
91,000
91,000
89,000
89,00091,00091,00094,00095,00095,00095,00095,00097,000100,000100,000105,000114,000143,341587,291592,730595,903622,463606,461591,341505,000505,000504,00000
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
4,061,000
5,407,000
4,914,000
6,081,192
4,396,541
-746,709
-677,374
-750,174
4,057,123
-572,106
-598,000
-519,000
5,582,000
-698,000
-769,000
-882,000
4,857,000
-663,000
-675,000
-651,000
-512,000
-449,000
-376,000
-376,000-449,000-512,000-651,000-675,000-663,0004,857,000-882,000-769,000-698,0005,582,000-519,000-598,000-572,1064,057,123-750,174-677,374-746,7094,396,5416,081,1924,914,0005,407,0004,061,00000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue9,587,000
Cost of Revenue-5,732,000
Gross Profit3,855,0003,855,000
 
Operating Income (+$)
Gross Profit3,855,000
Operating Expense-8,469,000
Operating Income1,118,000-4,614,000
 
Operating Expense (+$)
Research Development230,000
Selling General Administrative1,296,000
Selling And Marketing Expenses-
Operating Expense8,469,0001,526,000
 
Net Interest Income (+$)
Interest Income35,000
Interest Expense-74,000
Net Interest Income-39,000-39,000
 
Pretax Income (+$)
Operating Income1,118,000
Net Interest Income-39,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)1,105,0001,118,000
EBIT - interestExpense = 1,015,000
1,075,000
903,000
Interest Expense74,000
Earnings Before Interest and Taxes (ebit)1,089,0001,179,000
Earnings Before Interest and Taxes (ebitda)1,530,000
 
After tax Income (+$)
Income Before Tax1,105,000
Tax Provision-246,000
Net Income From Continuing Ops859,000859,000
Net Income829,000
Net Income Applicable To Common Shares829,000
 
Non-recurring Events
Discontinued Operations6,000
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-25,000
Total Other Income/Expenses Net-39,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
ZYDUSLIFE.BSE
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ZYDUSLIFE.BSE.

ZYDUSLIFE.BSE Daily Candlestick Chart
WHIRLPOOL.BSE
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WHIRLPOOL.BSE.

WHIRLPOOL.BSE Daily Candlestick Chart
ULTRACEMCO.BSE
5 minutes ago

I found you a Golden Cross on the daily chart of ULTRACEMCO.BSE.

ULTRACEMCO.BSE Daily Candlestick Chart
UMAEXPORTS.BSE
5 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UMAEXPORTS.BSE.

UMAEXPORTS.BSE Daily Candlestick Chart
TRITURBINE.BSE
6 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TRITURBINE.BSE.

TRITURBINE.BSE Daily Candlestick Chart
TRIVENIENT.BSE
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIVENIENT.BSE.

TRIVENIENT.BSE Daily Candlestick Chart
TIDEWATER.BSE
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TIDEWATER.BSE.

TIDEWATER.BSE Daily Candlestick Chart
LAND.JK
7 minutes ago

I found you a Death Cross on the daily chart of LAND.JK.

LAND.JK Daily Candlestick Chart
INRU.JK
7 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of INRU.JK.

INRU.JK Daily Candlestick Chart
PANKAJPO.BSE
8 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PANKAJPO.BSE.

PANKAJPO.BSE Daily Candlestick Chart
VICO.JK
8 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VICO.JK.

VICO.JK Daily Candlestick Chart
TBIG.JK
8 minutes ago

I found you a Death Cross on the daily chart of TBIG.JK.

TBIG.JK Daily Candlestick Chart
SMDM.JK
9 minutes ago

I found you a RSI Bearish Reversal Divergence on the daily chart of SMDM.JK.

SMDM.JK Daily Candlestick Chart
RUIS.JK
9 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of RUIS.JK.

RUIS.JK Daily Candlestick Chart
PBRX.JK
10 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PBRX.JK.

PBRX.JK Daily Candlestick Chart
LEAD.JK
11 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of LEAD.JK.

LEAD.JK Daily Candlestick Chart
SMCGLOBAL*.BSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SMCGLOBAL*.BSE.

SMCGLOBAL*.BSE Daily Candlestick Chart
SMCGLOBAL.BSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SMCGLOBAL.BSE.

SMCGLOBAL.BSE Daily Candlestick Chart
SHARDACROP.BSE
12 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHARDACROP.BSE.

SHARDACROP.BSE Daily Candlestick Chart
GLOB.JK
12 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of GLOB.JK.

GLOB.JK Daily Candlestick Chart
FIRE.JK
12 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of FIRE.JK.

FIRE.JK Daily Candlestick Chart
BRMS.JK
13 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of BRMS.JK.

BRMS.JK Daily Candlestick Chart
BIMA.JK
13 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of BIMA.JK.

BIMA.JK Daily Candlestick Chart
ASSA.JK
14 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of ASSA.JK.

ASSA.JK Daily Candlestick Chart